Scott Jackson is a Rare Disease Account Manager at Merck & Co. Inc., specializing in pulmonary arterial hypertension. They have received back-to-back President’s Circle awards in 2021 and 2022 while also excelling in previous roles in the cardiovascular market at AstraZeneca, Gilead Sciences, and Daiichi Sankyo. With 24 years of successful sales experience in pharmaceutical and hospital sales, Scott has demonstrated expertise across a range of therapeutic classes, achieving numerous accolades including Gold Cup and Chairman’s Club recognition. Scott holds a Bachelor of Science in Biology with a Chemistry concentration from Missouri Southern State University and is currently pursuing foreign language studies at The TEFL Academy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices